FLAT Prices Act

Summary

Official

Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.

How would you vote on this bill?

Yes No

Bill Progress

Bill has been introduced and assigned a number

Introduced(2/6/19)

Committee

Passed House

Passed Senate

President

Law

Sponsor

Mr. Durbin

Senate (D) Illinois

Cosponsors (6)

Brown

(D) OH

Harris

(D) CA

Klobuchar

Senate (D) Minnesota

Smith

Senate (D) Minnesota

Blumenthal

Senate (D) Connecticut

Peters

Senate (D) Michigan

Topics

Health

Government Spending & Operations

Science & Technology

Business & Finance

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)

Feb 6, 2019